While triple negative breast cancer (TNBC) is known to be heterogeneous at the genomic
and transcriptomic levels, spatial information on tumor organization and cell composition is …

Background Triple negative breast cancer (TNBC) is a heterogeneous disease
characterized by at least five molecular subtypes, namely basal like (BL) …

Triple-negative breast cancer (TNBC) is an aggressive disease that disproportionately
affects African American (AA) women. Limited targeted therapeutic options exist for patients …

Background Recent efforts of gene expression profiling analyses recognized at least four
different triple-negative breast cancer (TNBC) molecular subtypes. However, little is known …

Background Triple negative breast cancer (TNBC) accounts for 10–20% of all diagnosed
breast cancer cases in the US and is characterized by loss of HER2, estrogen receptors, and …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited
treatment options, which warrants identification of novel therapeutic targets. Deciphering …

Breast cancer remains a leading cause of mortality in women worldwide. Triple-negative
breast cancer (TNBC) is a particularly aggressive subtype characterized by rapid …

Background: Triple negative breast cancer (TNBC) is an aggressive subtype of breast
cancer that disproportionately affects African-American and black (AAB) women, who have …

Providing effective personalized immunotherapy for triple negative breast cancer (TNBC)
patients requires a detailed understanding of the composition of the tumor …

Objective: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer,
characterized by extensive intratumoral heterogeneity. We aimed to systematically …